University of Washington

Why trials sponsored by University of Washington stopped, in this sample of ClinicalTrials.gov.

21 stopped trials with a clear reason; 86% ended for non-scientific reasons.

Trials

• Testing Educational Videos on Conservative Kidney Management
  NCT06577571 · TERMINATED · slow accrual
  “Low recruitment, insufficient funds”
• OT-101 in Combination With Atezolizumab for the Treatment of Metastatic or Recurrent Non-Small Cell Lung Cancer
  NCT05935774 · WITHDRAWN · slow accrual
  “Withdrawn prior to opening to accrual.”
• Cabozantinib and Pembrolizumab for the First-Line Treatment of Advanced Liver Cancer
  NCT04442581 · TERMINATED · slow accrual
  “Terminated due to slow accrual”
• Umbralisib and Pembrolizumab in Treating Patients With Relapsed or Refractory Classical Hodgkin Lymphoma
  NCT03776864 · TERMINATED · funding business
  “Company providing drug terminated their oncology program”
• The Effects of Exercise on Distress, Quality of Life, and Biomarkers in Ovarian Cancer Survivors
  NCT03641287 · TERMINATED · funding business
  “Enrollment ended early due to the funding timeline”
• Lavage of the Uterine Cavity for Diagnosis of Ovarian Cancer
  NCT03606486 · TERMINATED · slow accrual
  “Terminated due to low accrual”
• Aldesleukin and Pembrolizumab in Treating Patients With Advanced or Metastatic Kidney Cancer
  NCT03260504 · TERMINATED · funding business
  “Insufficient funding”
• Apalutamide in Treating Patients With Prostate Cancer Who Are in Active Surveillance
  NCT02721979 · TERMINATED · slow accrual
  “Terminated due to slow accrual”
• Image Guided Hypofractionated Radiation Therapy, Nelfinavir Mesylate, Pembrolizumab, Nivolumab and Atezolizumab in Treating Patients With Advanced Melanoma, Lung, or Kidney Cancer
  NCT03050060 · TERMINATED · slow accrual
  “Terminated due to slow accrual”
• Washington Study of AxoTrack-Guided Central Venous Cannulation
  NCT03027323 · WITHDRAWN · funding business
  “Study not funded; no participants enrolled”
• Pembrolizumab in Treating Minimal Residual Disease in Patients With Acute Lymphoblastic Leukemia
  NCT02767934 · TERMINATED · futility
  “Terminated due to lack of efficacy”
• Genetic and Dietary Predictors of Anti-platelet Response
  NCT04456608 · TERMINATED · funding business
  “Funding ended before the study could be completed,”
• Myopia:the Role of Cone Opsin Mutations & Glasses That Control Axial Elongation
  NCT01923675 · WITHDRAWN · funding business
  “no funding”
• Collecting, Analyzing, and Storing Samples From Patients With Metastatic, Triple Negative Breast Cancer Receiving Anti-cancer Therapy
  NCT01957514 · TERMINATED · funding business
  “Terminated due to loss of funding.”
• Vaccine Therapy in Treating Patients With Stage IV Hormone Receptor Positive Breast Cancer
  NCT01729884 · TERMINATED · slow accrual
  “Study ended early due to slow enrollment”
• Adjustable Gastric Band Survey Study
  NCT01041534 · WITHDRAWN · slow accrual
  “This study did not enroll any participants”
• Raltegravir (Isentress/MK-0518) and HIV-1 Infected CD4 Cells During Acute/Early HIV-1
  NCT00781287 · TERMINATED · slow accrual
  “Enrollment too slow.”
• Sinusitis and Facial Pain Disorders Anti-Depression Trial
  NCT00754793 · TERMINATED · slow accrual
  “poor recruitment”
• Pegylated Liposomal Doxorubicin Hydrochloride, Bortezomib, Cyclophosphamide, and Dexamethasone in Treating Patients With Multiple Myeloma
  NCT00849251 · TERMINATED · funding business
  “One of the study drugs is not available.”
• Resuscitation Outcomes Consortium (ROC) Prehospital Resuscitation Using an Impedance Valve
  NCT00394706 · TERMINATED · futility
  “Terminated because preliminary data suggested no difference in the strategies.”
• A Study of HSV Testing Among Pregnant Women
  NCT00194415 · TERMINATED · futility
  “An interim data analysis found no significant difference between testing groups.”

Reasons are labeled automatically and are unverified. See the methodology. This is research information, not medical advice. Search the full database.